Mark C. Schneyer - 09 Dec 2021 Form 3 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role: Chief Financial Officer
Signature: /s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol: ACAD
Transactions as of: 09 Dec 2021
Net transactions value: $0
Form type: 3
Filing time: 20 Dec 2021, 17:00:22 UTC
Next filing: 25 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ACAD	Common Stock						1,303	09 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ACAD	Employee Stock Option (Right to Buy)							09 Dec 2021	Common Stock	41,066	$46.81	Direct	F1
holding	ACAD	Employee Stock Option (Right to Buy)							09 Dec 2021	Common Stock	19,927	$49.74	Direct	F2
holding	ACAD	Restricted Stock Units							09 Dec 2021	Common Stock	5,679		Direct	F3, F4
holding	ACAD	Restricted Stock Units							09 Dec 2021	Common Stock	5,411		Direct	F4, F5
holding	ACAD	Restricted Stock Units							09 Dec 2021	Common Stock	39,651		Direct	F4, F6
holding	ACAD	Restricted Stock Units							09 Dec 2021	Common Stock	39,651		Direct	F4, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the Stock Option vested and became exercisable on June 8, 2021, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F2	25% of the shares subject to the Stock Option vest and become exercisable on February 23, 2022, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F3	One-third of the shares subject to the restricted stock units vest on each of June 8, 2022, June 8, 2023 and June 8, 2024.
F4	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F5	The restricted stock units vest in four equal annual installments beginning February 23, 2022.
F6	The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.
F7	The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.